Does the FCGR2A rs1801274 GG (131R/R) genotype impair IgG2 immune-complex clearance and raise risk of immune-complex–mediated inflammatory disease?

The FCGR2A gene encodes the FcγRIIA receptor, a critical protein found on the surface of myeloid cells such as macrophages and neutrophils. This receptor facilitates the clearance of immune complexes (ICs)—aggregates of antibodies and antigens—which, if left in circulation, can trigger systemic inflammation and tissue damage. The rs1801274 single nucleotide polymorphism (SNP) is a primary genetic determinant of this receptor's functional efficiency.

Mechanistic explanations

• Amino Acid Substitution: The rs1801274 polymorphism involves a G>A transition, resulting in an Arginine (R) to Histidine (H) substitution at position 131 of the receptor's ligand-binding domain. The GG genotype corresponds to the homozygous 131R/R variant.
• Binding Affinity: The 131R variant (G allele) is characterized by a significantly lower binding affinity for human IgG2 compared to the 131H variant (A allele). This is biologically significant because FcγRIIA is the only human Fc receptor capable of efficiently interacting with the IgG2 subclass.
• Impaired Clearance: Reduced binding affinity directly translates to impaired antibody-dependent cellular phagocytosis (ADCP). In individuals with the GG genotype, the suboptimal capture of IgG2-containing immune complexes leads to their persistence in the bloodstream and subsequent deposition in tissues, promoting chronic inflammatory responses.

Clinical and effectiveness evidence

• Autoimmune Susceptibility: Meta-analytical data indicate that the G allele is a risk factor for various autoimmune conditions. In Asian populations, the G allele is associated with a significantly increased risk of systemic autoimmune diseases (OR = 1.378; 95% CI: 1.151–1.650).
• Disease Specificity: The association is particularly evident in systemic lupus erythematosus (SLE), where impaired IC clearance is a core pathogenic mechanism. Studies in specific cohorts, such as Korean populations, have confirmed the G allele's role in increasing SLE susceptibility, whereas the A allele often appears protective.
• Rheumatoid Arthritis (RA): While the link to RA susceptibility is less consistent across all ethnicities, the genotype influences treatment response; for instance, the AA (131H/H) genotype has been linked to better clinical outcomes with certain biological therapies compared to the GG genotype.

Bottom line

The FCGR2A rs1801274 GG genotype (131R/R) is a functional variant that reduces the clearance efficiency of IgG2 immune complexes. This impairment creates a pro-inflammatory environment that increases susceptibility to immune-complex–mediated diseases, including SLE, with risk intensity varying by ethnic background.